2021 Week 11: AbbVie Inc (NYSE: ABBV)


Portfolio Update

The FiveTwenty portfolio received $18.70 in the past week. WBA paid it’s quarterly dividend during the week.

Past Week Dividend$18.70
Current Quarter Dividend$84.57
Estimated Annual Dividend$741.17
LifeTime Dividend$84.57
Dividend Scorecard

The capital allocation for the week of 03/14/2021 to 03/20/2021 will be used to add to our position in AbbVie Inc (NYSE: ABBV)

ABBV – Update

Since out last check-in on ABBV in week 4 of 2021, the company reported Q4 and full year 2020 earnings on 02/03/2021. Additionally the share price has been more or less flat closing at $108.22 on 03/12/2021 compared to a close of $110.86 on 01/22/2021, 2.3% decline.

Continue reading “2021 Week 11: AbbVie Inc (NYSE: ABBV)”

What is a contingent consideration liability?

contingent consideration

In it’s Q4 2020 earnings release AbbVie (NYSE: ABBV) reported that it recorded a $4.7 billion increase in the contingent consideration liability for the drug Skyrizi. This expense wiped out ABBV’s net earnings for the quarter. Therefore, I decided to do some research to try to understand what a contingent consideration liability is.

What is a contingent consideration?

Contingent considerations are financial instruments employed in complex business transactions. Their purpose is to share risk associated with the transaction between buyers and sellers. A contingent consideration is an obligation of the buyer to transfer additional assets (cash, equity, physical assets) to the seller if future events occur or conditions are met.

Continue reading “What is a contingent consideration liability?”

2021 Week 4: AbbVie Inc (NYSE: ABBV)


The FiveTwenty portfolio received no dividends in the past week.

Past Week Dividend$0
Current Quarter Dividend$0
LifeTime Dividend$0
Dividend Scorecard

The capital allocation for the week of 01/24/2021 to 01/30/2021 will be used to establish a position in AbbVie Inc (NYSE: ABBV).

ABBV – Company Profile

AbbVie (ABBV) is a biopharmaceutical company founded in 2013 as a spin-off of Abbot Laboratories. The company develops and sells treatments in the areas of: immunology, hematologic oncology, aesthetics, neuroscience, eye care, women’s health and others. It’s best known products are Humira and Botox. Official Site | Wikipedia

Continue reading “2021 Week 4: AbbVie Inc (NYSE: ABBV)”